Share Price and Basic Stock Data
Last Updated: October 13, 2025, 10:16 pm
| PEG Ratio | -1.21 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Rupa & Company Ltd operates in the textiles sector, focusing primarily on hosiery and knitwear. For the fiscal year ending March 2025, the company reported sales of ₹1,239 Cr, a slight increase from ₹1,217 Cr in the previous year. The quarterly sales figures showed variability, with the highest recorded in March 2025 at ₹415.48 Cr, while June 2025 saw a drop to ₹183.90 Cr. The company’s market capitalization stands at ₹1,575 Cr, with a price-to-earnings (P/E) ratio of 19.8, indicating a moderate valuation compared to industry peers. The operating profit margin (OPM) fluctuated, with a high of 11.04% in March 2025. However, the overall trend in operating profit reflects challenges, as the operating profit for FY 2025 was ₹131 Cr, compared to ₹118 Cr in FY 2024. This variability in sales and profits suggests that Rupa’s revenue-generating capabilities are influenced by market conditions and operational efficiency.
Profitability and Efficiency Metrics
Rupa & Company has demonstrated mixed profitability metrics in recent years. The net profit for FY 2025 stood at ₹83 Cr, which is an improvement from ₹70 Cr in FY 2024, yet considerably lower than the ₹192 Cr reported in FY 2022. The return on equity (ROE) for the company is currently at 8.39%, while the return on capital employed (ROCE) is at 10.9%. These figures indicate that while the company is generating returns, they remain below optimal levels compared to industry benchmarks. The interest coverage ratio (ICR) is robust at 7.13x, reflecting the company’s ability to manage its interest obligations effectively. However, the cash conversion cycle (CCC) is at 340 days, suggesting that Rupa may face challenges in converting its investments in inventory and receivables into cash, which could impact liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
Rupa & Company has a relatively strong balance sheet, with total assets amounting to ₹1,512 Cr as of March 2025. The company reported reserves of ₹1,010 Cr, showcasing a sound capital base. Borrowings are relatively low at ₹238 Cr, leading to a debt-to-equity ratio of 0.22, indicating a conservative approach to leveraging. The liquidity ratios further enhance the financial stability, with a current ratio of 2.62 and a quick ratio of 1.65, both of which suggest that the company is well-positioned to meet its short-term obligations. However, the price-to-book value (P/BV) ratio stands at 1.40x, which could indicate that the stock is trading at a premium compared to its book value. As a result, while Rupa’s balance sheet appears strong, investors should remain cautious about valuation levels relative to its financial performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Rupa & Company reveals a strong promoter holding of 73.28%, which remains stable over several quarters. This indicates a significant level of confidence from the promoters in the company’s future. Institutional investors hold a minor stake, with Foreign Institutional Investors (FIIs) at 0.92% and Domestic Institutional Investors (DIIs) at 4.19%. The public holding stands at 21.60%, reflecting a diverse shareholder base with 61,191 shareholders as of March 2025. Despite the stable promoter holding, the low institutional interest may pose a risk to liquidity and broader market perception. The trend in public and institutional holdings, particularly given the recent fluctuations in stock performance, may influence investor sentiment and future capital flows.
Outlook, Risks, and Final Insight
If Rupa & Company can sustain its profitability margins and improve operational efficiency, it may position itself favorably within the textiles sector. The company’s ability to manage inventory and reduce the cash conversion cycle will be crucial for enhancing liquidity. Furthermore, addressing the fluctuations in sales and maintaining a steady growth trajectory will be essential for restoring investor confidence. Risks include potential market volatility impacting consumer demand and the ongoing challenges related to operational efficiency, which could hinder profitability. If the company can successfully navigate these challenges while leveraging its strong balance sheet, Rupa may enhance its competitive position and improve its financial performance in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Rupa & Company Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Filatex Fashions Ltd | 442 Cr. | 0.53 | 1.17/0.42 | 52.1 | 2.77 | 0.00 % | 0.63 % | 0.41 % | 1.00 |
| Alan Scott Industries Ltd | 177 Cr. | 325 | 345/91.8 | 3.28 | 0.00 % | 14.2 % | 142 % | 10.0 | |
| Addi Industries Ltd | 131 Cr. | 121 | 134/36.4 | 32.0 | 73.4 | 0.00 % | 5.51 % | 4.15 % | 5.00 |
| T T Ltd (TTL) | 264 Cr. | 10.2 | 19.5/9.20 | 3.49 | 0.49 % | 1.49 % | 8.57 % | 1.00 | |
| Rupa & Company Ltd | 1,575 Cr. | 198 | 292/174 | 19.8 | 128 | 1.52 % | 10.9 % | 8.39 % | 1.00 |
| Industry Average | 618.67 Cr | 125.94 | 39.00 | 84.30 | 0.38% | 6.49% | 18.42% | 4.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 214.67 | 285.62 | 236.00 | 406.79 | 195.44 | 302.09 | 318.51 | 400.48 | 210.29 | 297.10 | 316.44 | 415.48 | 183.90 |
| Expenses | 196.19 | 256.37 | 221.87 | 379.44 | 184.10 | 269.65 | 285.57 | 360.09 | 192.29 | 268.59 | 278.41 | 369.61 | 171.67 |
| Operating Profit | 18.48 | 29.25 | 14.13 | 27.35 | 11.34 | 32.44 | 32.94 | 40.39 | 18.00 | 28.51 | 38.03 | 45.87 | 12.23 |
| OPM % | 8.61% | 10.24% | 5.99% | 6.72% | 5.80% | 10.74% | 10.34% | 10.09% | 8.56% | 9.60% | 12.02% | 11.04% | 6.65% |
| Other Income | 5.61 | 3.17 | 2.60 | 4.79 | 3.24 | 4.40 | 4.18 | 1.15 | 4.72 | 4.33 | 4.40 | 4.32 | 3.77 |
| Interest | 5.81 | 6.47 | 5.85 | 4.76 | 5.21 | 5.19 | 5.40 | 4.85 | 4.85 | 5.03 | 5.87 | 5.03 | 4.77 |
| Depreciation | 3.31 | 3.36 | 3.31 | 3.28 | 3.45 | 3.81 | 3.75 | 3.72 | 3.61 | 3.66 | 3.64 | 3.58 | 3.69 |
| Profit before tax | 14.97 | 22.59 | 7.57 | 24.10 | 5.92 | 27.84 | 27.97 | 32.97 | 14.26 | 24.15 | 32.92 | 41.58 | 7.54 |
| Tax % | 16.83% | 25.32% | 26.95% | 21.62% | 28.55% | 26.26% | 25.71% | 26.45% | 26.65% | 23.64% | 27.70% | 26.43% | 26.79% |
| Net Profit | 12.45 | 16.87 | 5.52 | 18.89 | 4.22 | 20.53 | 20.78 | 24.24 | 10.46 | 18.44 | 23.80 | 30.59 | 5.52 |
| EPS in Rs | 1.57 | 2.12 | 0.69 | 2.38 | 0.53 | 2.58 | 2.61 | 3.05 | 1.32 | 2.32 | 2.99 | 3.85 | 0.69 |
Last Updated: August 20, 2025, 4:20 am
Below is a detailed analysis of the quarterly data for Rupa & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 183.90 Cr.. The value appears to be declining and may need further review. It has decreased from 415.48 Cr. (Mar 2025) to 183.90 Cr., marking a decrease of 231.58 Cr..
- For Expenses, as of Jun 2025, the value is 171.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 369.61 Cr. (Mar 2025) to 171.67 Cr., marking a decrease of 197.94 Cr..
- For Operating Profit, as of Jun 2025, the value is 12.23 Cr.. The value appears to be declining and may need further review. It has decreased from 45.87 Cr. (Mar 2025) to 12.23 Cr., marking a decrease of 33.64 Cr..
- For OPM %, as of Jun 2025, the value is 6.65%. The value appears to be declining and may need further review. It has decreased from 11.04% (Mar 2025) to 6.65%, marking a decrease of 4.39%.
- For Other Income, as of Jun 2025, the value is 3.77 Cr.. The value appears to be declining and may need further review. It has decreased from 4.32 Cr. (Mar 2025) to 3.77 Cr., marking a decrease of 0.55 Cr..
- For Interest, as of Jun 2025, the value is 4.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.03 Cr. (Mar 2025) to 4.77 Cr., marking a decrease of 0.26 Cr..
- For Depreciation, as of Jun 2025, the value is 3.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.58 Cr. (Mar 2025) to 3.69 Cr., marking an increase of 0.11 Cr..
- For Profit before tax, as of Jun 2025, the value is 7.54 Cr.. The value appears to be declining and may need further review. It has decreased from 41.58 Cr. (Mar 2025) to 7.54 Cr., marking a decrease of 34.04 Cr..
- For Tax %, as of Jun 2025, the value is 26.79%. The value appears to be increasing, which may not be favorable. It has increased from 26.43% (Mar 2025) to 26.79%, marking an increase of 0.36%.
- For Net Profit, as of Jun 2025, the value is 5.52 Cr.. The value appears to be declining and may need further review. It has decreased from 30.59 Cr. (Mar 2025) to 5.52 Cr., marking a decrease of 25.07 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.69. The value appears to be declining and may need further review. It has decreased from 3.85 (Mar 2025) to 0.69, marking a decrease of 3.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:10 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 904 | 973 | 1,015 | 1,093 | 1,120 | 1,149 | 975 | 1,313 | 1,475 | 1,143 | 1,217 | 1,239 | 1,213 |
| Expenses | 774 | 835 | 883 | 954 | 965 | 998 | 861 | 1,055 | 1,207 | 1,054 | 1,099 | 1,108 | 1,088 |
| Operating Profit | 130 | 138 | 132 | 139 | 155 | 151 | 114 | 257 | 269 | 89 | 118 | 131 | 125 |
| OPM % | 14% | 14% | 13% | 13% | 14% | 13% | 12% | 20% | 18% | 8% | 10% | 11% | 10% |
| Other Income | 7 | 5 | 4 | 3 | 2 | 2 | 7 | 7 | 11 | 16 | 13 | 18 | 17 |
| Interest | 25 | 24 | 19 | 11 | 8 | 19 | 19 | 13 | 19 | 23 | 21 | 21 | 21 |
| Depreciation | 11 | 15 | 15 | 16 | 16 | 15 | 19 | 14 | 14 | 13 | 15 | 14 | 15 |
| Profit before tax | 102 | 104 | 102 | 115 | 134 | 119 | 84 | 237 | 247 | 69 | 95 | 113 | 106 |
| Tax % | 35% | 35% | 35% | 37% | 36% | 38% | 26% | 26% | 22% | 22% | 26% | 26% | |
| Net Profit | 66 | 68 | 66 | 72 | 86 | 74 | 62 | 175 | 192 | 54 | 70 | 83 | 78 |
| EPS in Rs | 8.31 | 8.57 | 8.29 | 9.09 | 10.84 | 9.33 | 7.78 | 22.04 | 24.12 | 6.76 | 8.77 | 10.47 | 9.85 |
| Dividend Payout % | 30% | 32% | 33% | 30% | 28% | 32% | 39% | 23% | 12% | 44% | 34% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.03% | -2.94% | 9.09% | 19.44% | -13.95% | -16.22% | 182.26% | 9.71% | -71.88% | 29.63% | 18.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | -5.97% | 12.03% | 10.35% | -33.40% | -2.26% | 198.47% | -172.54% | -81.59% | 101.50% | -11.06% |
Rupa & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | -6% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 6% |
| 3 Years: | -24% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 0% |
| 3 Years: | -17% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 13% |
| 3 Years: | 7% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:10 pm
Balance Sheet
Last Updated: September 10, 2025, 2:24 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 278 | 320 | 359 | 431 | 491 | 537 | 570 | 722 | 874 | 904 | 950 | 1,010 |
| Borrowings | 198 | 212 | 148 | 84 | 116 | 210 | 179 | 161 | 370 | 258 | 235 | 238 |
| Other Liabilities | 176 | 202 | 166 | 192 | 284 | 261 | 234 | 265 | 325 | 218 | 253 | 256 |
| Total Liabilities | 661 | 742 | 681 | 716 | 899 | 1,016 | 991 | 1,156 | 1,577 | 1,388 | 1,446 | 1,512 |
| Fixed Assets | 145 | 137 | 156 | 169 | 167 | 182 | 185 | 193 | 210 | 233 | 244 | 241 |
| CWIP | 4 | 19 | 9 | 0 | 8 | 3 | 6 | 19 | 27 | 21 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 |
| Other Assets | 511 | 587 | 517 | 546 | 724 | 832 | 799 | 944 | 1,340 | 1,134 | 1,202 | 1,244 |
| Total Assets | 661 | 742 | 681 | 716 | 899 | 1,016 | 991 | 1,156 | 1,577 | 1,388 | 1,446 | 1,512 |
Below is a detailed analysis of the balance sheet data for Rupa & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,010.00 Cr.. The value appears strong and on an upward trend. It has increased from 950.00 Cr. (Mar 2024) to 1,010.00 Cr., marking an increase of 60.00 Cr..
- For Borrowings, as of Mar 2025, the value is 238.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 235.00 Cr. (Mar 2024) to 238.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 256.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 253.00 Cr. (Mar 2024) to 256.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,512.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,446.00 Cr. (Mar 2024) to 1,512.00 Cr., marking an increase of 66.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2024) to 241.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 27.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,244.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,202.00 Cr. (Mar 2024) to 1,244.00 Cr., marking an increase of 42.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,512.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,446.00 Cr. (Mar 2024) to 1,512.00 Cr., marking an increase of 66.00 Cr..
Notably, the Reserves (1,010.00 Cr.) exceed the Borrowings (238.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -68.00 | -74.00 | -16.00 | 55.00 | 39.00 | -59.00 | -65.00 | 96.00 | -101.00 | -169.00 | -117.00 | -107.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 69 | 62 | 70 | 114 | 126 | 94 | 101 | 135 | 138 | 146 | 151 |
| Inventory Days | 249 | 287 | 227 | 230 | 234 | 281 | 426 | 233 | 336 | 293 | 250 | 283 |
| Days Payable | 75 | 74 | 65 | 78 | 116 | 110 | 123 | 97 | 127 | 78 | 88 | 93 |
| Cash Conversion Cycle | 240 | 282 | 224 | 222 | 232 | 298 | 398 | 237 | 345 | 353 | 308 | 340 |
| Working Capital Days | 66 | 74 | 69 | 86 | 104 | 112 | 142 | 113 | 134 | 178 | 154 | 162 |
| ROCE % | 27% | 25% | 23% | 24% | 25% | 20% | 14% | 30% | 25% | 8% | 10% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 23,765 | 0.11 | 0.64 | 23,765 | 2025-04-22 15:56:53 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 10.47 | 8.77 | 6.76 | 24.12 | 22.04 |
| Diluted EPS (Rs.) | 10.47 | 8.77 | 6.76 | 24.12 | 22.04 |
| Cash EPS (Rs.) | 12.28 | 10.61 | 8.41 | 25.84 | 23.74 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 127.78 | 120.31 | 114.50 | 110.74 | 91.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 127.78 | 120.31 | 114.50 | 110.74 | 91.62 |
| Revenue From Operations / Share (Rs.) | 155.64 | 152.77 | 143.55 | 185.13 | 164.85 |
| PBDIT / Share (Rs.) | 18.61 | 16.81 | 13.20 | 35.08 | 33.23 |
| PBIT / Share (Rs.) | 16.79 | 14.96 | 11.54 | 33.33 | 31.50 |
| PBT / Share (Rs.) | 14.18 | 11.89 | 8.69 | 30.98 | 29.81 |
| Net Profit / Share (Rs.) | 10.46 | 8.76 | 6.75 | 24.09 | 22.01 |
| NP After MI And SOA / Share (Rs.) | 10.46 | 8.76 | 6.75 | 24.09 | 22.01 |
| PBDIT Margin (%) | 11.95 | 11.00 | 9.19 | 18.94 | 20.15 |
| PBIT Margin (%) | 10.78 | 9.79 | 8.03 | 18.00 | 19.10 |
| PBT Margin (%) | 9.11 | 7.78 | 6.05 | 16.73 | 18.08 |
| Net Profit Margin (%) | 6.72 | 5.73 | 4.70 | 13.01 | 13.35 |
| NP After MI And SOA Margin (%) | 6.72 | 5.73 | 4.70 | 13.01 | 13.35 |
| Return on Networth / Equity (%) | 8.18 | 7.28 | 5.89 | 21.75 | 24.02 |
| Return on Capital Employeed (%) | 12.73 | 12.02 | 9.67 | 28.69 | 32.55 |
| Return On Assets (%) | 5.51 | 4.82 | 3.87 | 12.16 | 15.02 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.22 | 0.23 | 0.26 | 0.40 | 0.19 |
| Asset Turnover Ratio (%) | 0.83 | 0.85 | 0.77 | 1.04 | 1.17 |
| Current Ratio (X) | 2.62 | 2.62 | 2.53 | 2.02 | 2.33 |
| Quick Ratio (X) | 1.65 | 1.69 | 1.42 | 1.13 | 1.34 |
| Inventory Turnover Ratio (X) | 1.38 | 1.14 | 0.94 | 1.58 | 1.14 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 34.19 | 44.40 | 20.72 | 13.61 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 28.23 | 35.61 | 19.32 | 12.61 |
| Earning Retention Ratio (%) | 0.00 | 65.81 | 55.60 | 79.28 | 86.39 |
| Cash Earning Retention Ratio (%) | 0.00 | 71.77 | 64.39 | 80.68 | 87.39 |
| Interest Coverage Ratio (X) | 7.13 | 6.48 | 4.64 | 14.92 | 19.70 |
| Interest Coverage Ratio (Post Tax) (X) | 5.01 | 4.56 | 3.37 | 11.25 | 14.05 |
| Enterprise Value (Cr.) | 1453.77 | 1900.06 | 1755.81 | 3720.98 | 2471.71 |
| EV / Net Operating Revenue (X) | 1.17 | 1.56 | 1.54 | 2.52 | 1.88 |
| EV / EBITDA (X) | 9.81 | 14.19 | 16.70 | 13.32 | 9.34 |
| MarketCap / Net Operating Revenue (X) | 1.15 | 1.56 | 1.42 | 2.37 | 1.87 |
| Retention Ratios (%) | 0.00 | 65.80 | 55.59 | 79.27 | 86.38 |
| Price / BV (X) | 1.40 | 1.98 | 1.78 | 3.96 | 3.36 |
| Price / Net Operating Revenue (X) | 1.15 | 1.56 | 1.42 | 2.37 | 1.87 |
| EarningsYield | 0.05 | 0.03 | 0.03 | 0.05 | 0.07 |
After reviewing the key financial ratios for Rupa & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.47, marking an increase of 1.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.47, marking an increase of 1.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.28. This value is within the healthy range. It has increased from 10.61 (Mar 24) to 12.28, marking an increase of 1.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.78. It has increased from 120.31 (Mar 24) to 127.78, marking an increase of 7.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.78. It has increased from 120.31 (Mar 24) to 127.78, marking an increase of 7.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 155.64. It has increased from 152.77 (Mar 24) to 155.64, marking an increase of 2.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.61. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.61, marking an increase of 1.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.79. This value is within the healthy range. It has increased from 14.96 (Mar 24) to 16.79, marking an increase of 1.83.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.18. This value is within the healthy range. It has increased from 11.89 (Mar 24) to 14.18, marking an increase of 2.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 8.76 (Mar 24) to 10.46, marking an increase of 1.70.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 8.76 (Mar 24) to 10.46, marking an increase of 1.70.
- For PBDIT Margin (%), as of Mar 25, the value is 11.95. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.95, marking an increase of 0.95.
- For PBIT Margin (%), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from 9.79 (Mar 24) to 10.78, marking an increase of 0.99.
- For PBT Margin (%), as of Mar 25, the value is 9.11. This value is below the healthy minimum of 10. It has increased from 7.78 (Mar 24) to 9.11, marking an increase of 1.33.
- For Net Profit Margin (%), as of Mar 25, the value is 6.72. This value is within the healthy range. It has increased from 5.73 (Mar 24) to 6.72, marking an increase of 0.99.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.72. This value is below the healthy minimum of 8. It has increased from 5.73 (Mar 24) to 6.72, marking an increase of 0.99.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.18. This value is below the healthy minimum of 15. It has increased from 7.28 (Mar 24) to 8.18, marking an increase of 0.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.73. This value is within the healthy range. It has increased from 12.02 (Mar 24) to 12.73, marking an increase of 0.71.
- For Return On Assets (%), as of Mar 25, the value is 5.51. This value is within the healthy range. It has increased from 4.82 (Mar 24) to 5.51, marking an increase of 0.69.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.22, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has decreased from 0.85 (Mar 24) to 0.83, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.62. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.62.
- For Quick Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.65, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 4. It has increased from 1.14 (Mar 24) to 1.38, marking an increase of 0.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 34.19 (Mar 24) to 0.00, marking a decrease of 34.19.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.23 (Mar 24) to 0.00, marking a decrease of 28.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.81 (Mar 24) to 0.00, marking a decrease of 65.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.77 (Mar 24) to 0.00, marking a decrease of 71.77.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.13. This value is within the healthy range. It has increased from 6.48 (Mar 24) to 7.13, marking an increase of 0.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.01. This value is within the healthy range. It has increased from 4.56 (Mar 24) to 5.01, marking an increase of 0.45.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,453.77. It has decreased from 1,900.06 (Mar 24) to 1,453.77, marking a decrease of 446.29.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.17, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 9.81. This value is within the healthy range. It has decreased from 14.19 (Mar 24) to 9.81, marking a decrease of 4.38.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.15, marking a decrease of 0.41.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 65.80 (Mar 24) to 0.00, marking a decrease of 65.80.
- For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.98 (Mar 24) to 1.40, marking a decrease of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.15, marking a decrease of 0.41.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rupa & Company Ltd:
- Net Profit Margin: 6.72%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.73% (Industry Average ROCE: 6.49%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.18% (Industry Average ROE: 18.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.8 (Industry average Stock P/E: 39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.72%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Hosiery/Knitwear | Metro Tower, 8th Floor, Kolkata West Bengal 700071 | connect@rupa.co.in http://www.rupa.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prahlad Rai Agarwala | Chairman |
| Mr. Ghanshyam Prasad Agarwala | Vice Chairman |
| Mr. Kunj Bihari Agarwal | Managing Director |
| Mr. Ramesh Agarwal | Whole Time Director |
| Mr. Mukesh Agarwal | Whole Time Director |
| Mr. Vikash Agarwal | Whole Time Director |
| Mr. Niraj Kabra | Executive Director |
| Mr. Ashok Bhandari | Independent Director |
| Mr. Sunil Rewachand Chandiramani | Independent Director |
| Mr. Joginder Pal Dua | Independent Director |
| Mr. Sumit Malhotra | Independent Director |
| Mrs. Mamta Binani | Independent Director |
| Mr. Arvind Baheti | Independent Director |
| Mr. Vijay Chhibber | Independent Director |
FAQ
What is the intrinsic value of Rupa & Company Ltd?
Rupa & Company Ltd's intrinsic value (as of 13 October 2025) is 172.69 which is 12.78% lower the current market price of 198.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,575 Cr. market cap, FY2025-2026 high/low of 292/174, reserves of ₹1,010 Cr, and liabilities of 1,512 Cr.
What is the Market Cap of Rupa & Company Ltd?
The Market Cap of Rupa & Company Ltd is 1,575 Cr..
What is the current Stock Price of Rupa & Company Ltd as on 13 October 2025?
The current stock price of Rupa & Company Ltd as on 13 October 2025 is 198.
What is the High / Low of Rupa & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rupa & Company Ltd stocks is 292/174.
What is the Stock P/E of Rupa & Company Ltd?
The Stock P/E of Rupa & Company Ltd is 19.8.
What is the Book Value of Rupa & Company Ltd?
The Book Value of Rupa & Company Ltd is 128.
What is the Dividend Yield of Rupa & Company Ltd?
The Dividend Yield of Rupa & Company Ltd is 1.52 %.
What is the ROCE of Rupa & Company Ltd?
The ROCE of Rupa & Company Ltd is 10.9 %.
What is the ROE of Rupa & Company Ltd?
The ROE of Rupa & Company Ltd is 8.39 %.
What is the Face Value of Rupa & Company Ltd?
The Face Value of Rupa & Company Ltd is 1.00.